Invesco Dorsey Wright Utilities Momentum ETF (PUI)
Live price chart, market sentiment, and community perspectives for Invesco Dorsey Wright Utilities Momentum ETF (NASDAQ: PUI).
Live price chart, market sentiment, and community perspectives for Invesco Dorsey Wright Utilities Momentum ETF (NASDAQ: PUI).
On our desk, we are looking closely at how PUI implements its Dorsey Wright price momentum methodology. While the fund aims to capture relative strength across at least 30 U.S. utility firms, the trailing 1-year return of 7.77% significantly underperforms the broader utilities category average of 24.77%. For a niche vehicle with around $54.6M in net assets, this lag suggests that its systematic momentum filters may be slow to adapt or are getting caught in sector rotation headwinds. Investors chasing pure sector performance might find themselves frustrated by the rules-based lag during sudden market shifts.
Watching the fund's asset allocation and valuation metrics, PUI trades right around $45.65 with a trailing P/E ratio of 21.77 and a dividend yield of 2.51%. The underlying sector weighting heavily leans into utilities at over 85%, supplemented by minor allocations to energy and industrials. However, market commentary and risk discussions highlight that momentum strategies carry a distinct Achilles' heel: they can dramatically underperform during abrupt market reversals or when leadership changes swiftly. Given its concentrated exposure, any macro shock to rate-sensitive utilities could severely test its downside protection.
When evaluating PUI for portfolio construction or tactical sector plays, quantitative researchers must account for its unique creation/redemption mechanics and historical trading volumes, which average around 3.05K daily. Because ETF shares are only redeemable in Creation Units typically ranging from 10,000 to 150,000 shares, liquidity at the retail level requires careful execution. Furthermore, tracking a custom momentum index means analysts need to monitor quarterly rebalancing turnover and factor exposures closely to ensure the fund isn't buying lagging names at the top of a momentum cycle.
Explore plasma cleansing, somatic organ swaps, and BCI.